
Sign up to save your podcasts
Or
"We only learned to change human DNA 10 years ago; we as a species are 200,000 years old. So gene editing to treat disease is not even in its infancy - it's in its first minute of being born. To say that we have no idea whether to use it to make changes to future generations would be the understatement of all time. I mean, this is the equivalent of taking our ancestors who roamed Neolithic Europe and putting them in a Tesla."
In this week's episode of The G Word, Chris is joined by Fyodor Urnov, Director of Technology & Translation at the Innovative Genomics Institute and Professor of Molecular and Cell Biology at the University of California, Berkeley. Listed on the 2014 Thomson Reuters list as one of 'The World's Most Influential Scientific Minds', he has authored over 100 scientific publications, invented more than 130 US patents and won the Presidential Award for Excellence in Teaching at Brown University.
Fyodor discusses genome editing, his involvement in the US's effort to test for COVID-19 and CRISPR technology. He also talks about his education and academia.
4.8
44 ratings
"We only learned to change human DNA 10 years ago; we as a species are 200,000 years old. So gene editing to treat disease is not even in its infancy - it's in its first minute of being born. To say that we have no idea whether to use it to make changes to future generations would be the understatement of all time. I mean, this is the equivalent of taking our ancestors who roamed Neolithic Europe and putting them in a Tesla."
In this week's episode of The G Word, Chris is joined by Fyodor Urnov, Director of Technology & Translation at the Innovative Genomics Institute and Professor of Molecular and Cell Biology at the University of California, Berkeley. Listed on the 2014 Thomson Reuters list as one of 'The World's Most Influential Scientific Minds', he has authored over 100 scientific publications, invented more than 130 US patents and won the Presidential Award for Excellence in Teaching at Brown University.
Fyodor discusses genome editing, his involvement in the US's effort to test for COVID-19 and CRISPR technology. He also talks about his education and academia.
752 Listeners
4,266 Listeners
897 Listeners
954 Listeners
248 Listeners
43,357 Listeners
111,441 Listeners
80 Listeners
2,782 Listeners
2,965 Listeners
2,144 Listeners
12,723 Listeners
3,172 Listeners
317 Listeners
0 Listeners